Immunic market cap
WitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat... Witryna7 kwi 2024 · MoneyLion Inc.’s market cap currently stands at around $133.26 million, with investors looking forward to this quarter’s earnings report slated for May 10, 2024 – May 15, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.06, which has seen fiscal year 2024 EPS growth forecast to increase to -$0.21 and about …
Immunic market cap
Did you know?
WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net WitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Immunic market cap as of September 23, 2024 is $0.1B .
Witryna17 lis 2024 · November 17, 2024. NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the formation of a Scientific-Medical … Witryna12 kwi 2024 · GSK PLC (LSE:GSK, NYSE:GSK)’s growth outlook is being overlooked and the worst-case scenario for Zantac continues to be reflected in the share price. That’s the view of Shore Capital which reiterated a buy on the pharma giant with a 1,850p share price target. The broker thinks GSK has made some steady inroads to …
WitrynaMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Immunic (IMUX)
Witryna6 kwi 2024 · In depth view into Immunic Market Cap including historical data from 2014, charts and stats. Immunic Inc (IMUX) ... Market Capitalization measures the total …
Witryna23 godz. temu · View Immunic, Inc IMUX investment & stock information. Get the latest Immunic, Inc IMUX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Market Cap 61.28 M Dividend 0. ... slow time cheat sims 4Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. PR Newswire. November 3, 2024, 3:30 AM · 16 min read. – $72.8 Million in Cash and Cash Equivalents as ... slow time chieriWitryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage … sohail atifWitrynaAs of March 2024 Immunic has a market cap of $70.15 Million . This makes Immunic the world's 6697th most valuable company by market cap according to our data. The … slow time cadenceWitrynaImmunic, cost to borrow history and number of IMUX shares available to borrow. companies: 7,324 total market cap: $87.045 T. Global ranking; Ranking by countries. … sohail auto brokersWitryna31 mar 2024 · Immunic has a market cap or net worth of $66.16 million as of April 1, 2024. Its market cap has decreased by -79.28% in one year. Market Cap 66.16M. … slowtimecafe 群馬WitrynaCurrent and historical revenue charts for Immunic. As of March 2024 Immunic's TTM revenue is of N/A. companies: 7,320 total market cap: $84.507 T. Global ranking; … sohail azad 3oym